Mouth Pipetting: A Threat More Difficult to Eradicate than Small Pox

Berg P. , Baltimore D. , Brenner S. , Roblin R. O. III & Singer M. F. 1975. Summary statement of the Asilomer conference on recombinant DNA molecules. Proc. Nat. Acad. Sci., 6:1981–84.

Blazer M. J. , Hickman F. W. , Farmer J. J. III , Brenner D. J. , Balows A. & Feldman R. A. 1980. Salmonella typhi: The laboratory as a reservoir of infection. J. Infect. Dis., 142:934–938.

Federal Register. 1976. National Institutes of Health Recombinant DNA Research Guidelines. Fed. Regist., 41: 27902–27943 (July 7, 1976).

Federal Register. 1976. National Institutes of Health Recombinant DNA Research Guidelines, Appendix D. Fed. Regist., 41:27926–27943 (July 7, 1976).

Federal Register. 1978. National Institutes of Health Recombinant DNA Research Proposed Revised Guidelines. Fed. Regist., 43:33044 (July 28, 1978).

Federal Register. 1978. National Institutes of Health Recombinant DNA Research Revised Guidelines. Fed. Regist., 43:60080–60105 (December 22, 1978).

Federal Register. 1991. 29 CFR Part 1910.1030. Occupational exposure to bloodborne pathogens; final rule. Fed. Regist. 56:64176 (December 6, 1991).

Hellman A. , Oxman M. N. & Pollack R. , eds. 1973. Biohazards in Biomedical Research. Cold Spring Harbor Laboratory. Cold Spring Harbor, New York.

U.S. Department of Health Education and Welfare (DHEW), National Institutes of Health, National Cancer Institute. 1974. National Cancer Institute Safety Standards for Research Involving Oncogenic Viruses. DHEW Publication No. (NIH) 75–790. U.S. Government Printing Office. Washington, D.C.

U.S. Department of Health and Human Services (DHHS), Public Health Service, Centers for Disease Control and Prevention, and National Institutes of Health. 1984. Biosafety in Microbiological and Biomedical Laboratories, 1st ed. Richardson J. H. & Barkley W. E. , eds. DHHS Publication No. (CDC) 84–8395. U.S. Government Printing Office. Washington, D.C.